ArticleBlood advances2020

Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia.

Haesook T Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.